Absci
absci.com
Actively hiring
Drug Discovery
Drug Discovery AI
Biologics & Biosimilars
As featured in
View 1 job
Claim pageClaim
Follow
Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Jobs
Financials
Overview
Absci is a generative biology company that combines deep learning with high-throughput laboratory screening to design therapeutic antibodies. Founded in 2011 and headquartered in Vancouver, Washington, it runs an integrated drug creation platform that proposes candidate sequences computationally and validates millions of them experimentally. The company develops its own pipeline and also partners with pharmaceutical firms on AI-designed biologics.
News
Parkman Healthcare Partners LLC Acquires New Shares in Absci Corporation $ABSI
Parkman Healthcare Partners LLC acquired a new position in shares of Absci Corporation (NASDAQ:ABSI - Free Report) in the second quarter, according to its most recent 13F filing with the SEC. The institutional investor acquired 894,374 shares of the compa
Read more
Report
Absci (ABSI) Following Phase 1 Data And Lilly Backing Still Looks Undervalued
Absci (ABSI) is back in focus after interim Phase 1 data for its ABS-201 program indicated favorable safety, tolerability, and pharmacokinetics, along with a recent $100 million funding round anchored by Eli Lilly.See our latest analysis for Absci.Absci's
Read more
Report
Absci (ABSI) Q2 2026 Earnings Call Transcript
Detailed price information for Absci Corp (ABSI-Q) from The Globe and Mail including charting and trades.
Read more
Report
The Zacks Analyst Blog Highlights Recursion Pharmaceuticals, Schrodinger, Relay Therapeutics and Absci
Detailed price information for Recursion Pharmaceuticals Inc Cl A (RXRX-Q) from The Globe and Mail including charting and trades.
Read more
Report
Absci Corporation (NASDAQ:ABSI) Receives Consensus Rating of "Moderate Buy" from Analysts
Absci Corporation (NASDAQ:ABSI - Get Free Report) has been assigned a consensus recommendation of "Moderate Buy" from the nine brokerages that are currently covering the stock, MarketBeat reports. One analyst has rated the stock with a sell rating and eig
Read more
Report
Absci (NASDAQ:ABSI) Stock Rating Upgraded by Wall Street Zen
Wall Street Zen raised shares of Absci from a "sell" rating to a "hold" rating in a report on Saturday.
Read more
Report
Absci (NASDAQ:ABSI) Receives "Buy" Rating from Needham & Company LLC
Needham & Company LLC restated a "buy" rating and set a $11.00 price objective on shares of Absci in a report on Wednesday.
Read more
Report
Absci reports $33.2M Q2 loss, secures $100M funding
Absci Corporation posted a Q2 2026 net loss of $33.2 million with revenue of $0.3 million. The company advanced its clinical pipeline with positive Phase 1 data for ABS-201 and secured $100 million in funding, including a strategic investment from Eli Lil
Read more
Report
Absci (NASDAQ:ABSI) Posts Quarterly Earnings Results, Misses Expectations By $0.02 EPS
Absci (NASDAQ:ABSI - Get Free Report) issued its quarterly earnings data on Tuesday. The company reported ($0.21) EPS for the quarter, missing analysts
Read more
Report
Absci Reports Business Updates and Second Quarter 2026 Financial and Operating Results
Announced positive interim Phase 1 data from the HEADLINE trial of ABS-201Completed $100 million underwritten offering, including $40 million str...
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Absci over the last 12 months, by layer, with the share of postings for each.
Technologies in use
9
Postings analysed
10
Stack modernity
71/100
Languages
Python20%
Frameworks & libraries
PyTorch20%
Cloud & platforms
GCP40%
Weights & Biases10%
Sign in to see how your skills match this stack
Sign In
Full Absci tech stack
9 technologies · by team · pay by technology · changes · similar stacks
Salary insights
Compensation ranges based on this company's open jobs
Median
$200k
Typical range
$150k – $355k
Open positions
7
6
Jobs
Junior
16.7%
Senior
33.3%
Staff
16.7%
Architect
33.3%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 1 | $150k | $150k |
| Senior | 2 | $263k | $200k – $325k |
| Staff | 1 | $183k | $183k |
| Architect | 2 | $298k | $240k – $355k |
Highest paying role
Vice President, Clinical Operations
$355k
Normalized to USD per year
All salaries at Absci
By role, level and city, against the market · 7 jobs with pay
People
Phil Barish
Executive Officer, Director
Sean McClain
Executive Officer, Director
Shelley Klassen
Executive Officer
Gregory Schiffman
Executive Officer
Lawrence McClure
Executive Officer
Zach Jonasson
Director
Bryan Lawlis
Director
Daniel Gold
Director
Gustavo Mahler
Director
Bryan Lawliss
Director
Zach Zach Jonasson
Director
V. Lawlis
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data
Growth
Hiring Momentum
86/100
Scaling fast
Open positions
7
3 opened / 1 closed in 30 days
Median time-to-fill
42 days
faster than 31% of the market
ATS activity
Every ~3 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Early Careers
30% ▲
AI/ML
20% ▼
Product
10% ▼
HR
10% ▲
Legal
10% ▲
Operations
10% ▲
Activity Timeline
New location: New York
Oct 2026
New location: United States
Sep 2026
Added YouTube to stack
Sep 2026
Added LinkedIn to stack
Sep 2026
Added Machine Learning to stack
Sep 2026
Added GDPR to stack
Sep 2026
Added GCP to stack
Sep 2026
Added Scrum to stack
Sep 2026
Added Agile to stack
Sep 2026
Added World Models to stack
Sep 2026
Added Edge AI to stack
Aug 2026
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
1
Countries
2
Busiest office
Vancouver
Loading the map
Headquarters
Builds here
Office with open vacancies
No open vacancies right now Tap a pin for the office
Portland
United States
HQ
Vancouver
Canada
1 open roles 3 posted in 90 days 100% remote 10-50 est. staff $193k Avg Salary
hires for Operations
Jobs
$113k – $184k per year • Hybrid • Full-Time • 3+ years exp • PhD • United States
Python
Computer Vision
PyTorch
Edge AI
Machine Learning
Apply
Financials
Est. Annual Revenue
$3M
2018
Total raised
$321M
Latest round
Venture - Series Unknown
Funding rounds
6
Revenue
Estimate
Low-high range
Modelled from public signals, not audited accounts - read it as an order of magnitude.
| Year | Estimate | Low | High |
|---|---|---|---|
| 2015 | $500k | $1 | $1M |
| 2018 | $3M | $1M | $5M |